Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Breast cancer risk: It's not all in the family

CHICAGO (Reuters) - Women do not automatically have a higher risk of getting breast cancer just because someone else in the family has tested positive for breast cancer genes, U.S. researchers said Monday.

Doctors split on Avastin for breast cancer: survey

NEW YORK (Reuters Health) - An international survey of cancer doctors shows many question U.S. health advisers' 2010 rejection of Roche's drug Avastin to treat advanced breast cancer.

Mammogram results often wrong, U.S. study finds

CHICAGO (Reuters) - More than half of healthy women who have an annual mammogram will get at least one false positive result over a 10-year period, and 7 to 9 percent will undergo a biopsy that doesn't turn out to show cancer, according to U.S. researchers.

Antioxidants tied to mixed effects in breast cancer

NEW YORK (Reuters Health) - Breast cancer patients who take antioxidants may have an increased or decreased risk of death or recurrent cancer, depending on which vitamin they use, a new study suggests.

Breast cancer drug tied to diabetes in older women

NEW YORK (Reuters Health) - Older women taking the breast cancer drug tamoxifen may have an increased risk of developing diabetes, a new study suggests.

Early breast cancer screening may help some: study

NEW YORK (Reuters Health) - Starting breast cancer screening as early as age 25 may help women who carry a genetic mutation linked to a higher risk of cancer live longer, suggests a new study.

Calif. insurer won't pay for breast cancer drug

(Reuters) - Health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial.

Novartis's Afinitor shows promise in breast cancer

STOCKHOLM (Reuters) - Combining two drugs from Novartis and Pfizer to treat post-menopausal women with a certain type of advanced breast cancer more than doubled the time they lived without their disease getting worse, study data showed on Monday.

Breast cancer study shows benefits of double therapy

STOCKHOLM (Reuters) - Giving breast cancer patients radiotherapy and chemotherapy at the same time significantly cuts the risk their tumors will come back and should be considered as a new treatment approach across the world, cancer experts said on Sunday.

Poor women get more unneeded breast cancer surgery

NEW YORK (Reuters Health) - Old, poor and Hispanic women are all more likely to have lymph nodes under the armpit removed unnecessarily during breast cancer surgery, a new study finds.

Close
close